Introduction {#sec1}
============

Patellofemoral joint (PFJ) osteoarthritis (OA) is identified on radiographs as osteophytes and loss of articular cartilage on patella or in the femoral trochlear groove [@bib1]. PFJ OA is an important source of knee symptom after ACL injury. Symptoms of anterior knee pain, swelling, and functional limitations such as difficult to go up and down stairs, squatting or rising from a seated position are disabilities found in patients with PFJ OA [@bib2], [@bib3]. In recent years, many papers reported that the prevalence of PFJ OA after ACL injury is increased, regardless of whether ACL reconstruction (ACLR) is performed [@bib4], [@bib5]. This early onset of OA and its associated pain and functional limitations pose a particular challenge to younger adults when compared with an older OA population. Lee et al. reported that 17.4% of patients had newly developed PFJ OA after ACLR (38.9 ​± ​5.4 months of follow-up) [@bib6]. A study reported that the prevalence of PFJ is 72% (15-years-follow-up) and 80% (20-years-follow-up) after ACLR [@bib7]. A review by Culvenor et al. reported that radiographic PFJ OA after ACLR, with a prevalence ranging from 11% to 90% (median 36%), 2--15 years after surgery [@bib4]. For comparison, the overall crude prevalence of radiographic PFJ OA was 17% in healthy individuals [@bib8]. These emerging evidences suggest that although less well recognized compared with tibiofemoral joint (TFJ) OA, PFJ OA after ACL injury should be paid more attention to alleviate joint symptoms and functional limitations. However, the modifiable factors in treatment to alleviate degenerative changes in the PFJ after ACL injury remain unknown. Targeted interventions need to be developed to alleviate joint symptoms and functional limitations of PFJ OA after ACL injury. Therefore, we would like to conduct a systematic review to synthesize these evidences, assess the quality of the studies we found, and formulate conclusions and recommendations based on study findings. Besides, the reported prevalence of PFJ OA after ACL deficiency in the literature has large variations and has no consensus, likely reflecting different radiographic diagnostic criteria used, different surgical procedures, different follow-up period after surgery, and heterogeneous populations. Therefore, the overall prevalence of PFJ OA after ACL deficiency based on different radiographic diagnostic criteria, surgical procedures, follow-up period, and populations via systematic search remains unknown.

Many studies have reported the OA outcome in the knee after ACL injury [@bib9], [@bib10], [@bib11]. However, many of them either did not specify the OA compartment in the knee, or focused on TFJ only. The PFJ has different biomechanical features from the TFJ and could be affected by ACLR in a different manner. Kim et al. reported that despite a clinically satisfactory ACLR (with negative anteroposterior drawer and pivot shift tests), patients showed at least one region with increased T2 value of the PFJ cartilage 3 years after ACLR, especially at the medial compartment of the trochlear cartilage [@bib12]. The risk factors associated with PFJ OA after ACL injury have not been systematically summarised. Identification of the risk factors may assist in preventing or reducing PFJ OA after ACL injury in future studies to improve clinical outcome. Targeted interventions need to be developed to reduce the burden of early-onset OA following ACLR.

The published paper presented two questions: What is the prevalence of PFJ OA after ACL injury reported in the literature? which risk factors are associated with the development of degenerative changes on the PFJ after ACL injury? This review will do a systematic search, systematically summarise the reported prevalence of PFJ OA in populations on the base of study quality assessment, and identify what risk factors and elements that less recognized in the literature are associated with the development of PFJ OA after ACL injury.

Methods {#sec2}
=======

Search strategies {#sec2.1}
-----------------

We performed a comprehensive search in databases including MEDLINE (OVID), Pubmed, Embase, and WoS and up to 1 March 2019. The key search terms are as shown in [Table 1](#tbl1){ref-type="table"}. We only included studies evaluating PFJ OA with or without TFJ OA after ACL injury. Whether descripted the specified compartment of TFJ OA or not would not have an influence in the study selection. Similar search strategies were used in WoS, Embase, and MEDLINE (OVID). In addition, other relevant publications from reference lists were also included.Table 1Search strategies in MEDLINE.Table 11Anterior cruciate\*\[tw\] OR acl\[tw\];2injur\* \[tw\] OR tear\* \[tw\] OR ruptur\* \[tw\] OR deficien\* \[tw\] OR tear\* \[tw\]3(osteoarthrit\*\[tw\] OR osteo-arthrit\*\[tw\] OR osteoarthro\*\[tw\] OR osteo-arthro \[tw\] OR arthrosis\[tw\] OR arthroses\[tw\] OR arthrot\*\[tw\] OR gonarthro\*\[tw\] OR degen\*\[tw\])4(risk\*\[tw\] OR factor\*\[tw\] OR risk factor \*\[tw\] OR population at risk OR populations at risk OR prevalence\[MeSH\]

Study selection {#sec2.2}
---------------

The searched studies were assessed based on the following inclusion criteria:

Full text available;

Written in English;

Study design could be as follows: randomised controlled trial, prospective cohort study, and retrospective study;

ACL reconstructed patients who had accepted primary ACLR; use of an arthroscopic and use of hamstring tendon/bone-patellar tendon-bone (BPTB)/allografts;

ACL injury patients with conservative treatment;

The number of included subjects must be more than 20;

OA outcomes including: radiographic OA, OA findings on MRI/ during arthroscopy;

Follow-up period of at least 2 years;

Animal studies, cadaveric studies, case series, letters, case reports, and reviews were excluded. Studies including patients without skeletally immature knees were also excluded.

Data extraction and analysis {#sec2.3}
----------------------------

To evaluate the reported prevalence of PFJ OA, results from the radiologic and MRI assessments were extracted from the included studies. For the cut off value in defining PFJ OA, In the present review, after comparing the grading of different classification system, Kellgren and Lawrence (KL) Grade 2, IKDC Grade B, Fairbank Grade 1, Ahlbäck Grade 1, joint space narrowing based on OARSI Grade 2 or higher (or a sum of osteophyte grades of ≥2, or Grade 1 JSN in combination with a Grade 1 osteophyte), and MRI Osteoarthritis Knee Score (MOAKS) Grade 1 was used to define as PFJ degenerative changes. The reason we used such grading to define PFJ OA was that these grading from different system share similar severity of degenerative changes in the PFJ: definite osteophytes and/or possible JSN. Meta-analysis for proportions with random effects model were performed using MedCalc for Windows, V.16.8 to calculate pooled prevalence of PFJ OA and (odd ratios) ORs of associated risk factors. Heterogeneity tests were also conducted and interpreted as follows: I^2^\<25%, low heterogeneity; 25% ​≤ ​I^2^ ​≤ ​75%, moderate heterogeneity; and I^2^\>75%, high heterogeneity. Data were pooled based on the following study populations: (1) ACL reconstructed population with BPTB graft; (2) ACL reconstructed population with HS graft; (3) ACL reconstructed population with single-bundle graft; (4) ACL reconstructed population with double-bundle graft; (5) ACL deficient population with conservative treatment (non-ACL reconstruction); (6) Early ACL reconstruction; (7) Delayed ACL reconstruction. (8) Follow-up periods: 2--5 years; 6--10 years; over 10 years. We also calculated the pooled ORs of incurring PFJ OA between ACL reconstructed populations and conservative treatment populations. In addition, funnel plots generated by Medcalc (V.16.8) was used to visually inspect the existence of publication biases and/or between study heterogeneity. In the absence of biases and/or between study heterogeneity, funnel plot will be a symmetrical inverted funnel in shape. Funnel plots of ORs of ACLR inducing PFJ OA were made to inspect the existence of publication biases.

Study quality assessment {#sec2.4}
------------------------

A modified version of the Coleman methodology score (CMS) was used to assess the methodological quality of the included studies ([Appendix 1](#appsec1){ref-type="sec"}) [@bib13]. The CMS originally consisted of 10 criteria with a total score ranging from 0 to 100. A score of 100 indicated the most high-quality study with no confounding factors or other biases. The criteria were based on the Consolidated Standards of Reporting Trials (CONSORT) statement for randomised controlled trials. The CMS was originally developed for surgical treatment of tendinopathy, but modified versions of the CMS have been used in other reviews [@bib14], [@bib15].The following criteria were altered for part A: (1) "Mean of follow-up (yrs)" (question 2) was altered from mean follow up (mths) and the range of follow up is modified accordingly, (2) "type of study" (question 4) was altered to give both prospective cohort studies and randomised controlled trials the highest score, (3) "description of postoperative treatment" (question 7) was removed. Part A gave a total score of 50. The following modifications were included in part B: (1) "Outcome criteria" (question 1) was altered; the original criterion concerning sensitivity was removed, and the score was given to studies that reported interrater or intrarater reliability for the radiologic assessments. Part B gave a total score of 40. The maximum score of the modified CMS was therefore 90. The modified CMS is listed in [Appendix 1](#appsec1){ref-type="sec"}. The methodological quality of the included studies was assessed by 2 independent reviewers (Wenhan HUANG and Tim-Yung ONG). Conflicting scores for the various items were discussed until consensus was reached. It is suggested in the literature that a score of more than 55% of total score for other checklists is to be considered as a high-quality study [@bib16].

Results {#sec3}
=======

Identification and selection of the literature {#sec3.1}
----------------------------------------------

The search resulted in 1454 studies, for which all abstracts were reviewed. Twenty-five additional studies from relevant reference lists were also included. After screening of the abstracts, 59 were identified as possibly relevant, and full texts were retrieved. After review of the full texts, 38 met all the inclusion criteria ([Figure 1](#fig1){ref-type="fig"}).Figure 1Flow-chart of studies included in the current systematic review.Figure 1

There were no disagreements on inclusions. The references of the 2 studies were reviewed and 4 additional studies meeting the inclusion criterion were identified. The characteristics of the included studies are presented in [Table 2](#tbl2){ref-type="table"}. Among them, 16 prospective studies and 22 retrospective studies were included in this systematic review. Four of the prospective studies were randomised controlled studies [@bib17], [@bib18], [@bib19], [@bib20].Table 2Summary of the main characteristics of the included studies.Table 2Additional informationNYears since ACLRGrading systemPFJ OA prevalence (%)Surgical procedureReported risk factorsMildModSevereSignificantNonsignificantBarenius et al. [@bib18] 2014ACLR with BPTB6914KL22(≥Mild)NANAArthroscopic BPTB ​+ ​HSBMI; medial meniscus resectionAge at injury;  graft type; sex; overweight, time between injury and reconstruction, lateral meniscus resectionACLR with HS6525(≥Mild)Culvenor et al. [@bib29] 2013ACLR with HS707OARSI47(≥Mild)NANAArthroscopic HSArticular cartilage lesions; late duration to ACLRMeniscus injury; intermediate duration to ACLRØiestad et al. [@bib25] 2012[b](#tbl2fnb){ref-type="table-fn"}ACLR with BPTB18112KL195.51Arthroscopic BPTBIncreased age; TFJ OAknee laxity; self-reported knee function; quadriceps strength; Hop tests up to two years postoperativelyNeuman et al. [@bib40] 2008ACLR with BPTB2215OARSI47(≥Mild)NANAArthroscopic BPTBACLRMeniscal injuryNon-ACLR608.3(≥Mild)Lohmander et al. [@bib22] 2004ACLR with BPTB/HS3112OARSI20(≥Mild)NANAArthroscopic BPTB ​+ ​HSACLRSymptoms; activity levelNon-ACLR263.8(≥Mild)Meer et al. [@bib23] 2016ACLR with BPTB/HS932KL11.8NANAArthroscopic BPTB ​+ ​HSMeniscectomy during the first year after ACL traumaAge at operation; sex; BMI; Tegner activity score; effusion; meniscal tearNon-ACLR508Frobell et al. [@bib17] 2013Early ACLR585KL24(≥Mild)NANAArthroscopic BPTB ​+ ​HSACLRDelayed ACLR2921(≥Mild)Non-ACLR267.7(≥Mild)Culvenor et al. [@bib39] 2016[b](#tbl2fnb){ref-type="table-fn"}ACLR-15-year follow-up18115KL72(≥Mild)NANAArthroscopic BPTBAnterior knee painACLR-20-year follow-up2080(≥Mild)Cantin et al. [@bib48] 2016ACLR58912IKDC8(≥Mild)20Arthroscopic BPTB ​+ ​ITB ​+ ​HSRisberg et al. [@bib9] 2016ACLR-15-year follow-up16815KL21(≥Mild)NANAArthroscopic BPTB ​+ ​HSACLR-20-year follow-up20Ahn et al. [@bib37] 2011ACLR with BPTB11710IKDC4993Arthroscopic BPTBBreitfuss et al. [@bib32] 1996ACLR with BPTB412Fairbank25(≥Mild)NANAArthroscopic BPTBCohen et al. [@bib28] 2007ACLR with BPTB6211Fairbank52230Arthroscopic BPTBJärvelä et al. [@bib43] 2001ACLR with BPTB1007IKDC34121Arthroscopic BPTBKeays et al. [@bib49] 2007[a](#tbl2fna){ref-type="table-fn"}ACLR with HS276Modified KL41.300Arthroscopic BPTB ​+ ​HSACLR with BPTB2929.600Murray et al. [@bib11] 20128313IKDC65101Arthroscopic BPTBSajovic et al. [@bib19] 2006ACLR with HS285IKDC17(≥Mild)NANAArthroscopic BPTBACLR with BPTB2650(≥Mild)NANASalmon et al. [@bib50] 2006ACLR with BPTB4913IKDC2600Arthroscopic BPTBBourke et al. [@bib51] 2012ACLR with HS11815IKDC1101Arthroscopic HSHertel et al. [@bib52] 2005ACLR with BPTB6710IKDC600Arthroscopic BPTBKarikis et al. [@bib20] 2016ACLR with single-bundle415Fairbank2330Arthroscopic HSACLR with double-bundle46940Tsoukas et al. [@bib24] 2016ACLR with BPTB/HS3210.1IKDC64NANAArthroscopic BPTB ​+ ​HSNon-ACLR1360Mascarenhas et al. [@bib53] 2012ACLR with BPTB365KL57NANAArthroscopic BPTB ​+ ​HSACLR with HS4726Li et al. [@bib54] 2011ACLR with BPTB/HS2497.8KL1010Arthroscopic BPTB ​+ ​HSHui et al. [@bib55] 2011ACLR with BPTB5015IKDC1420Arthroscopic BPTBKeays et al. [@bib10] 2010[a](#tbl2fna){ref-type="table-fn"}ACLR with HS296KL41.300Arthroscopic BPTB ​+ ​HSACLR with BPTB2729.600Fithian et al. [@bib56] 2005Non-ACLR1136.6IKDC57NANAArthroscopic BPTBEarly ACLR6376Late ACLR3360Wang et al. [@bib35] 2003ACLR with BPTB444.8Ahlback11.4NANAArthroscopic BPTBEdwards et al. [@bib57] 2000ACLR with BPTB/HS458IKDC22.28.90Arthroscopic BPTB ​+ ​HSJarvela et al. [@bib58] 1999Early ACLR487IKDC41.66.30Arthroscopic BPTBDelayed ACLR4328.813.30Thompson et al. [@bib59] 2015ACLR with BPTB8020IKDC18130Arthroscopic BPTBRuffilli et al. [@bib60] 2014ACLR with single-bundle2012.1IKDC20200Arthroscopic HSACLR with double-bundle312200Franceschi et al. [@bib33] 2013ACLR with anteromedial portal465Fairbank7.1NANAArthroscopic HSACLR with transtibial portal4215.2Holm et al. [@bib61] 2012Open ACLR2512KL20NANAArthroscopic & Open BPTBArthroscopic ACLR2836Suomalainen et al. [@bib41] 2012Double-bundle ACLR with bioabsorbable screw fixation205KL2500Arthroscopic HSSingle-bundle ACLR with bioabsorbable screw fixation213800Single-bundle ACLR with metallic screw fixation242500Sim et al. [@bib38] 2015673.6IKDC4.500Arthroscopic HSSward et al. [@bib31] 2013ACL injured with varus alignment3615OARSI2200NAACL injured with valgus/neutral alignment29700Liden et al. [@bib34] 2008ACLR with HS417.2Fairbank500Arthroscopic BPTB ​+ ​HS[^1][^2][^3]

Totally 4254 subjects were included in the studies, with samples ranging from 22 to 589. The mean follow-up time is 9.48 ​± ​5.67 years. In 5 studies, not only PFJ were radiologically assessed in ACL deficient population with conservative treatment, but radiologically assessed in ACL reconstructed population [@bib17], [@bib21], [@bib22], [@bib23], [@bib24]. Surgical procedures for the ACLR reported in the studies were using hamstring, BPTB grafts, or iliotibial tract with or without augmentations. Preoperative PFJ OA was reported in 5 studies. Particularly, preoperative radiographic assessment was included in 10 studies.

Methodological quality {#sec3.2}
----------------------

The results of the study quality assessments are presented in [Table 3](#tbl3){ref-type="table"}. Thirty-one studies can be regarded as high-quality studies based on the modified CMS. For part A, "type of study" and "number of treatment procedures" gave the lowest scores. For part B, the lowest scores were achieved for "outcome criteria" and "description of subject selection process." None of the studies fulfilled all the criteria (modified CMS of 90). The mean modified CMS was 58.89 ​± ​11.54, which corresponds to a CMS of 65.43 when transferred to a 0 to 100 score. The lowest score achieved was 39, and the highest score is 80 found in two studies [@bib9], [@bib25]. The prospective studies achieved a mean modified CMS of 70.06, with the highest score of 80 and the lowest score of 52. The retrospective studies correspondingly achieved a mean modified CMS of 59.3, with the highest score of 58 and the lowest score of 39.Table 3Modified Coleman methodology score for included studies.Table 3Section Score (Maximum)Mean (SD)**Part A**Study size (10)8.74Mean duration follow-up(5)4.89No. of treatment procedures (10)0.53Type of study (15)5.92Diagnostic certainty (5)5Description of surgical procedure (5)3.84**Part BOutcome criteria (10)5.74**Outcome measured clearly (4)4Reported interrater or intrarater reliability (3)0.95Use of outcome criteria that has reported good reliability (3)0.79**Procedure for assessing outcomes (15)12.60**Subjects recruited (5)5Investigator independent of surgeon/therapist (4)2.00Written assessment (3)2.84Completion of assessment by subjects themselves with minimal investigator assistance (3)2.76**Description of subject selection process (15)11.89**Selection criteria reported and unbiased (5)3.68Recruitment rate reported (≥80% ​= ​5; \<80% ​= ​3)4.26Eligible subjects not included in the study accounted for (5)3.95Total part A (50)28.66(6.94)Total part B (40)30.23 (5.72)Total score (90)59.89(11.54)[^4]

Prevalence reported in included studies {#sec3.3}
---------------------------------------

Because the definition for PFJ varied in different studies, various cutoff values for defining PFJ OA in the included studies were used to define as PFJ OA. The cut--off values chosen was described in methods section. The cut-off point used in the current systematic review was consistent with previous studies [@bib26], [@bib27]. The overall prevalence of PFJ OA in the included studies varied between 4.5% and 80% ([Table 2](#tbl2){ref-type="table"}). Only 4 studies reported the PFJ OA alone and rest of the included studies focus on both PFJ and TFJ.

ACL reconstructed population {#sec4}
============================

In ACL reconstructed population with BPTB graft, the overall prevalence of PFJ OA from 20 studies was (mean proportion: (95% CI)) 38.9% (29.4--48.9%) ([Figure 2](#fig2){ref-type="fig"}). In ACL reconstructed population with HS graft, the overall prevalence of PFJ OA from 13 studies was 23.0% (15.7--31.3%). In ACL reconstructed population with single-bundle graft, the overall prevalence of PFJ OA from 3 studies was 31.6% (23.3--40.6%). In ACL reconstructed population with double-bundle graft, the overall prevalence of PFJ OA from 3 studies was 19.1% (12.1--27.4%). In early ACL reconstructed population, the overall prevalence of PFJ OA from 2 studies was 8.1% (3.9--13.5%). In delayed ACL reconstructed population, the overall prevalence of PFJ OA from 2 studies was 40.3% (8.2--78.2%). In ACL reconstructed population with different follow-up, the overall prevalence of PFJ OA is 20.4% (14.8--26.5%, 2--5 years), 32.5% (20.9--45.3%, 6--10 years), and 31.8% (22.0--42.5%, over 10 years), respectively.Figure 2Prevalence of PFJ OA in ACL reconstructed population with BPTB/HS grafts, double-bundle/single-bundle reconstruction, non-ACLR/early ACLR/delayed ACLR. BPTB, bone-patellar tendon-bone; HS, hamstring; CI, confidence interval; PFJ, patellofemoral joint; OA, osteoarthritis; ACL, anterior cruciate ligament; ACLR, anterior cruciate ligament reconstruction.Figure 2

ACL deficient population with conservative treatment {#sec5}
====================================================

In ACL deficient population with conservative treatment, the overall prevalence of PFJ OA from 7 studies was 20.3% (95% CI: 6.5--39.1%). We also investigated the relationship between the prevalence of PFJ OA and modified CMS ([Figure 3](#fig3){ref-type="fig"}). No obvious trend was found between them but large prevalence variations were shown in lower quality studies. In the two studies with highest MCS score, the prevalence is 21% [@bib9] and 25% [@bib25], separately. For the prospective study, the prevalence of PFJ OA is between 10.7% and 80%, among them the randomised controlled study reported as between 13% and 26%. For the retrospective study, the figure is between 4.5% and 75%. One study evaluated the association between meniscectomy in ACLR population and PFJ OA and the prevalence reported is 75% [@bib28].Figure 3The overall prevalence scatter plots of included studies with corresponding modified CMS. CMS, Coleman methodology score.Figure 3

Radiologic classification methods {#sec5.1}
---------------------------------

Five different radiologic classification methods were used in the 37 included studies. Only one reported the PFJ OA prevalence of 11.8% after ACL injury using MOAKS [@bib23]. Seventeen studies used the IKDC classification system ([Figure 4](#fig4){ref-type="fig"}). The reported prevalence of PFJ OA in these studies was between 4.5% and 65%. The KL classification system was used in 11 studies. The reported prevalence of PFJ OA in these studies was between 21% and 80%. The OARSI classification system was used to grade JSN and osteophytes in 4 studies with a reported prevalence of PFJ OA from 20% to 47%, respectively [@bib21], [@bib22], [@bib29], [@bib30], [@bib31]. One study used the KL to grade OA in TFJ; however, the researchers did not specify radiologic classification system but used JSN and osteophyte formation [@bib17]. This study reported a prevalence of 17% of PFJ OA. Five studies used the Fairbank classification system with a reported prevalence of PFJ OA between 11.4% and 52% [@bib20], [@bib28], [@bib31], [@bib32], [@bib33], [@bib34]. The KL showed variant prevalence of PFJ OA, which made the prevalence inconsistent (21%--80%). JSN by OARSI also exhibited inconsistent prevalence of PFJ OA. Only one study used the Ahlbäck classification system with a reported prevalence of 11.4% in PFJ OA [@bib35]. Most of the studies reported that the radiographs were performed with the patients in the standing position with full weight bearing (n ​= ​27) and with a knee flexion angle of 15°--45° (n ​= ​21).Figure 4The overall prevalence scatter plots of included studies using different radiologic classification systems: MOAKS, MRI Osteoarthritis Knee Score; YS, years. KL, Kellgren and Lawrence; JSN, joint space narrowing; IKDC, International Knee Documentation Committee; MOAKS, MRI Osteoarthritis Knee Score.Figure 4

Risk factors inducing PFJ OA after ACLR {#sec5.2}
---------------------------------------

Seven risk factors were identified inducing PFJ OA after ACL injury ([Table 2](#tbl2){ref-type="table"}). Among them, ACLR was the most frequently reported risk factors. The odds ratios of risk of incurring PFJ OA varied between 0.81 and 9.62 in five studies that included both ACLR population and non-ACLR population after ACL rupture [@bib17], [@bib21], [@bib22], [@bib23], [@bib24]. The pooled ORs of incurring PFJ OA between ACL reconstructed populations and conservative treatment populations is 2.1 (95% CI: 1.1 to 3.9) ([Figure 5](#fig5){ref-type="fig"}).Figure 5Forest plot of comparison: Risk factors and associations with conservative treatment and ACLR. OR, odds ratio; CI, confidence interval; ACLR, anterior cruciate ligament reconstruction.Figure 5

Identification of risk factors using logistic regression analysis was conducted in 6 studies to determine the effect of each potential risk factor on the odds of a patient having PFJ OA. Risk factors identified in these 6 studies were BMI [@bib18], delayed ACLR [@bib29], meniscectomy, patellofemoral chondral lesions, and age at surgery [@bib25], more TFJ OA [@bib29]. In the remaining studies, risk factors were identified using Poisson regression and discriminant analysis. Risk factors reported were ACLR [@bib21], age at the time of operation [@bib25] and presence of chondral injury [@bib29]. One study not only evaluated the odds ratios of PFJ OA in both ACLR population and non-ACLR population after ACL rupture, but performed logistic regression to determine odds ratios of the candidate risk factors in relevant factors [@bib22].

Publication bias was assessed by visual inspection of funnel plots for ORs of ACLR inducing PFJ OA ([Figure 6](#fig6){ref-type="fig"}). The plots demonstrate that some asymmetry was found regarding the ORs of ACLR incurring PFJ OA.Figure 6Funnel plots of the standard error (SE) and odd ratio (OR) for ACLR (\*: early ACL reconstruction in study by Fithina et al., 2005; Δ: late ACL reconstruction in study by Fithina et al., 2005). ACLR, anterior cruciate ligament reconstruction.Figure 6

Discussion {#sec6}
==========

Prevalence of PFJ OA after ACL injury {#sec6.1}
-------------------------------------

The overall prevalence of PFJ OA in included studies varied between 4.5% and 80%. For comparison, the overall crude prevalence of isolated radiographic PFJ OA was 7% in community-based populations in a systematic review [@bib8]. The reported prevalence of PFJ OA is between 11.8% and 80% for the prospective studies with a modified CMS of 49--74. For the retrospective studies, the prevalence varied between 4.5% and 76% with a modified CMS of 37--59. All the 38 included studies reported the PFJ OA for subjects with or without concomitant meniscectomy in ACL reconstructed populations, and none of them reported in an isolated ACLR population. Specially, some studies reveal that menisci in different regions plays a different role in the development of PFJ OA. Meer et al. show that medial meniscal injury/meniscectomy influences PFJ OA while lateral meniscal injury/meniscectomy does not [@bib36].

The pooled prevalence of PFJ OA based on different follow-up period showed that in the early stage, the prevalence is low (20.4%); afterwards, it increased by 10% in the following 5 years. However, the pooled data showed that no obvious increase after that and even a little decrease was shown. It might be caused by the increasing sample size with the increase of follow-up, which enables us to get a smaller margin of error and get the true prevalence.

Radiologic grading systems {#sec6.2}
--------------------------

Five different radiologic classification methods based on evaluation of osteophyte formation, JSN, or both were used in the 37 included studies. One study graded PFJ OA according to the description of MOAKS with MRI. We admit that there are some mild differences of pathological stages among different classification system. Despite of these variations, the selected cutoff values can be representative of moderate to severe degenerative changes in the PFJ, we believe that the definition for PFJ OA is consistent and may not be a large concern. After we categorising the prevalence of PFJ OA based on different systems, no obvious underestimation or overestimation was found under different systems. It indicates that radiographic classification system variations might not have a great impact on the reporting prevalence of PFJ OA. The cutoff grade for defining PFJ OA using different grading systems is various in the included 38 studies. IKDC was used in 17 included studies, with parameters graded as normal (A), nearly normal (B), abnormal (C), or severely abnormal (D). Only two studies defined PFJ OA clearly [@bib37], [@bib38]. The onset of OA was defined as Grade C or D in patients whose preoperative grade was A or B in the study by Ahn et al. [@bib37], while Grade B, C, and D were regarded as degenerative arthritis changes in the study by Sim et al. [@bib38]. The KL classification was used in 11 studies with Grade 0--4. Four studies used Grade 2 as the cutoff for the presence of radiographic PFJ OA [@bib9], [@bib18], [@bib25], [@bib39]. Fairbank was used in 5 studies with Grade 0--4 and no definition for PFJ OA was given in these included studies. Besides, these studies did not report the criteria they used for different grade levels. Osteophytes and JSN were scored in PFJ using the OARSI in four studies [@bib17], [@bib22], [@bib29], [@bib40]. In these four studies, the definition for PFJ OA is consistent and JSN of Grade 2 or higher, sum of osteophyte grades ≥2 or grade 1 JSN in combination with a Grade 1 osteophyte was defined as PFJ OA. Only one study used Alhback with grade classification [@bib35]. Neither definition of PFJ OA nor the classification was given in this study. Particularly, one study identified early degenerative changes by assessment on MRI according to the description of MOAKS reported by Meer et al. [@bib23]. The features are categorized from grad 0 to 3 in cartilage lesions, osteophytes, and bone marrow lesions.

Risk factors inducing PFJ OA after ACL injury {#sec6.3}
---------------------------------------------

Eight studies identified the risk factors inducing PFJ OA after ACL injury, including ACLR, delayed ACLR, BMI, meniscectomy, patellofemoral chondral lesions, and age at surgery, more TFJ OA. Among them, ACLR was the most frequently reported risk factor. For studies not only evaluating the OR in ACLR population but in non-ACLR population after ACL injury, we found that the OR values varied between 0.81 and 9.62. Moreover, among these studies, the highest quality studies reported that the prevalence of PFJ OA after ACLR after 14-years follow-up was 23% (average age at end point: 40 years old) [@bib18] and 2-year follow-up 20.5% (single bundle reconstruction; average age at end point: 38 years old) & 24% (double bundle reconstruction) [@bib41], respectively. The pooled prevalence of PFJ OA in normal subjects aged 40 is not reported in the literature; however, for comparison, the pooled prevalence of PFJ OA in normal subjects aged 60 is 21.9% (95% CI: 16.9%-27.8) [@bib42]. It means that for a same prevalence of PFJ OA, the age of ACLR population is 20 years earlier than that of normal subjects. In addition, all these studies had the subject inclusion criteria including the time from injury to the beginning of the treatment, and thus, the time was the same in the ACLR population and non-ACLR population in each study. It means that the PFJ condition was similar in these two populations before treatment; however, due to surgery, the ACLR population has higher chance for the development of PFJ OA.

Generally, the prevalence of PFJ OA in ACLR group is higher than that in non-ACLR group, which indicates that ACLR is essentially a risk factor inducing PFJ OA ([Figure 3](#fig3){ref-type="fig"}-H). As a risk factor, ACLR has many contributors, including graft types [@bib43]; single-bundle and double-bundle techniques [@bib20]; PFJ biomechanical changes caused by graft tension. In a recent study, it is reported that all patients (10/10) showed at least one region with increased T2 value of the PFJ cartilage 3 years after ACLR, especially at the medial compartment of the trochlear cartilage [@bib44]. The forest plots show that BPTB, single-bundle reconstruction, and delayed ACLR are more likely to be associated with PFJ degenerative changes after ACL injury when compared to hamstring tendon, double-bundle reconstruction, and early ACLR.

Methodological quality {#sec6.4}
----------------------

The current systematic review showed that the mean modified CMS was 58.9 ​± ​11.5, which corresponds to a CMS of 65.4 when transferred to a 0 to 100 score. Another similar systematic review investigating knee OA after ACL deficiency revealed a mean CMS of 52 [@bib14]. The CMS assesses the study quality of reporting, and it has been shown that the score correlated positively with the level-of-evidence rating [@bib45]. The treatment procedure section in part A resulted in the lowest score in all included studies, as description or outcome of rehabilitation was seldom present. Only 11 studies reported either interrater or intrarater reliability, ranging from 0.51 to 0.78 that depends on specified outcome measurement system. These results are similar to those reported in other systematic review [@bib14], [@bib45]. Ten studies scored 3 points in "use of outcome criteria that has reported good reliability", as only in these 10 studies was the KL used. All included studies fulfilled the requirement in the following categories: mean follow-up, diagnostic certainty, and subjects recruited (results not taken from surgeons' files). The two studies with highest modified CMS (80) are prospective non-randomised studies, and they scored in every section except treatment procedure in part A [@bib9], [@bib25]. They are representatives of high assessment quality studies with standardised methods and recommended to present the true prevalence of PFJ OA after ACLR (21% and 25%, respectively) [@bib46].

Regarding publication bias, multiple sources have been identified that may affect funnel plot asymmetry including reporting bias. In the present review, for ORs of ACLR inducing PFJ OA, the funnel plot asymmetry is mainly due to different timing of surgery (early or late ACLR) and different follow-up period (2--15 years). One study fall out of the 95% CI axis due to the significantly high OR (OR ​= ​9.62) [@bib40].

Summary {#sec7}
=======

Although ACL injury and ACLR are well-established risk factors for the development of TFJ OA, PFJ OA after ACLR has gone largely un-recognised. In the present systematic review, PFJ OA after ACL deficiency was conducted in terms of epidemiological data, clinical definitions, and associated risk factors. The pooled prevalence of PFJ OA after ACL deficiency indicated us the prevalence of PFJ OA is a common clinical problem; The associated risk factors identified in this systematic review are crucial findings for the clinicians to reduce the prevalence of PFJ OA after ACL deficiency. In the present systematic review, the innovations are that that the overall prevalence of PFJ OA after ACL injury in the included studies varied between 4.5% and 80% based on different radiographic classification systems. The pooled prevalence of PFJ OA after ACL injury implied that we underestimated the degenerative changes in the PFJ after ACL injury with conservative or surgical treatment.

The substantial variation of PFJ OA prevalence is mainly due to the use of surgical techniques, and different follow-up periods. The pooled data showed that BPTB, single-bundle reconstruction, and delayed ACLR was more likely to induce PFJ degenerative changes after ACL injury compared to HS, double-bundle reconstruction, and early ACLR. In particular, ACLR itself, which is the main treatment to ACL injury, was a risk factor for the development of PFJ OA after ACL injury. These findings indicated that hamstring graft, double-bundle reconstruction, and early ACLR should be recommended to reduce the potential degenerative changes in the PFJ during ACLR. Modified rehabilitation strategies aimed to reduce PFJ OA after ACL injury should also be investigated in future studies to improve clinical outcome.

Some other findings from this review are that radiographic assessment should be done in standardized radiographic procedures. From this review, although we found that classification system variations did not have a significant impact on the reporting of the prevalence of PFJ OA, the KL should be recommended as a radiologic assessment to make outcome comparison easy based on its high interrater reliability. The X-rays taken, the baseline information of the included subjects, the technical issues with regard to taking patellofemoral X-rays, the results of opposite knee, and the recruitment rate should be reported, and attempts should be made to account for patients who are not included and those who are lost to follow-up. For patients undergone ACLR after ACL injury, the protocols and outcomes of rehabilitation should be reported. Due to lack of randomized controlled studies, future studies on the reported prevalence of PFJ OA should be randomized and controlled. Apart from the proposed improvement listed above, approaches to improve graft healing after ACLR such as intraoperative irrigation should also be systematically reviewed to evaluate if these approaches benefit the PFJ because some researchers found that the intraoperative irrigation had some improvement in knee laxity after ACLR [@bib47].

This systematic review has some limitations. First, a customised definition of PFJ OA was present in this systematic review as there is no consistent criteria in published literature. This may generate selection bias with respect to reporting the prevalence of PFJ OA. Second, as some studies focused on outcome measurement under different kinds of intervention rather than focussing on PFJ OA, the presented risk factors may not be available in different studies. Third, the prevalence of PFJ OA in ACLR with or without meniscectomy or other concomitant injury was not reported. This is because the included studies did not evaluate the concomitant effect from other anatomical structures beside ACLR. Fourth, the methodological quality assessment, modified CMS, has shortages in assessing the methodological quality of studies involving both surgically and nonsurgically treated subjects with ACL injury. Fifth, this systematic review only included English-language studies, which may introduce a language bias and lead to erroneous conclusions.

Conflict of interest {#sec8}
====================

The authors have no conflicts of interest to disclose in relation to this article.

Appendix 1. Modified Coleman methodology score[a](#dtbl1){ref-type="table-fn"} {#appsec3}
==============================================================================

SectionNumber or factorScoreCriteria**Part A**Only one score to be given for each section Study size: number of patients\>601041--60720--404\<20, not stated0Mean follow-up, y\>552--53\<20No. of different treatment procedures included in each reported outcome. More than 1 method may be assessed, but separate outcomes should be reported.1 procedure10Surgical methods and/or nonoperative treatment methodsMore than 1 method but \>90% of subjects undergoing the 1 procedure7Not stated, unclear, or \<90% of subjects undergoing the 1 procedure0Type of studyProspective cohort study/randomized controlled trial15Retrospective cohort study/case series0Diagnostic certaintyIn all5ArthroscopyIn \>80%3In \<80%0Description of treatment givenAdequate (technique stated and necessary details of that type of procedure given)5Fair (technique only stated without 3 elaboration) 3Inadequate, not stated, or unclear0**Part B**Scores could be given for each option in each of the 3 sectionsOutcome criteriaOutcome measures clearly defined4Radiologic classification and standing positionReported either interrater or intrarater 3 reliability3Use of outcome criteria that has reported good reliability3Kellgren and LawrenceProcedure for assessing outcomesSubjects recruited (results not taken from surgeons\' files)5Radiologic assessment performedInvestigator independent of surgeon/therapist4Radiologist independent of the authors of the studyWritten assessment3Use of questionnaires for evaluation of osteoarthritisComplection of assessment by subjects themselvrs with minimal investigator assistance3WOMAC, KOOS, IKDC, Lysholm, Tegner/return-to- sport questionnaireDescription of subject selection processSelection criteria reported and unbiased5Inclusion criteriaRecruitment rate reported \>80%5Radiologic assessmentRecruitment rate reported \<80%3Radiologic assessmentEligible subjects not included in the study satisfactorily accounted for, or 100% recruitment5Dropout analysisTotal score90[^5]

Appendix ASupplementary data {#appsec1}
============================

The following is the Supplementary data to this article:

Supplementary data to this article can be found online at <https://doi.org/10.1016/j.jot.2019.07.004>.

[^1]: N, number of included subjects; IKDC, International Knee Documentation Committee; KL, Kellgren and Lawrence; OARSI, Osteoarthritis Research Society International; NA, not applicable; PFJ, patellofemoral joint; TFJ, tibiofemoral joint; BPTB: bone-patellar tendon-bone; HS, hamstring.

[^2]: The same group patients were reported in these two studies by Keays et al. and same prevalence were reported.

[^3]: The same group patients were reported in these two studies by Oiestad et al. and Culvenor et al. in different follow-up periods.

[^4]: SD, standard deviation.

[^5]: The modified Coleman methodology score criteria used on the studies reporting PFJ OA after ACLR.
